Systems and methods for implanting an endovascular shunt in a patient is disclosed. The system having an expandable anchor configured for being deployed in a dural venous sinus of a patient at a location distal to a curved portion of a wall of an inferior petrosal sinus (IPS) of the patient; an elongate guide member coupled to, and extending proximally from, the anchor; a shunt delivery catheter having a first lumen configured to receive the guide member, and a second lumen extending between respective proximal and distal openings in the shunt delivery catheter, the shunt delivery catheter further having a penetrating element coupled to a distal end of the catheter; and the system further having a guard at least partially disposed over, and movable relative to, the penetrating element.

Systems, catheters, and methods for accessing and treating along the central nervous system are disclosed. An example method may manage inflammation of the patient to treat a condition of the patient by processing values related to one or more physiological parameters of a patent, identifying when an inflammation condition of the patient has reached a treatment condition based on the processed values, and automatically providing an indication that the inflammation condition has reached the treatment condition. An example indication may include actuation of a treatment protocol. The example method may be performed with an inflammation management system.

A dural venous sinus (DVS) implant anchor includes a body comprising a first portion extending in a first longitudinal direction, a second portion extending in a second longitudinal direction opposite the first longitudinal direction, and a connector portion coupled to the first portion and the second portion at an offset depth that corresponds to a depth of a first part of a thickness of a skull of a subject. When the DVS implant anchor is disposed within a DVS burr hole in the skull of the subject, the first portion extends along an outside surface of the skull and the second portion is at least partially disposed within the DVS burr hole.

Insertion tool for inserting at least a part of a medical device into a subject, insertion device comprising the insertion tool and an insertion mechanism, and method for manufacturing the insertion tool, wherein the insertion tool comprises a penetrating portion that comprises a composite material comprising at least one first material and at least one second material. Wherein the first material is an amorphous material or amorphous composite and the second material is a fibrillary material or fibrillary composite or a crystalline material or crystalline composite. A fluid absorption of the first material of the composite material is higher than a fluid absorption of the second material of the composite material, and the insertion device is adapted to soften when in contact with a body fluid at least due to the fluid absorption of the amorphous material or amorphous composite.

A cranial shunt implantable into a patient, the cranial shunt may comprise a first catheter, a second catheter and a valve assembly operatively coupled with the first and second catheters, the valve assembly comprising an inlet and a microcontroller, wherein the first catheter transfers cerebrospinal fluid (CSF) to the inlet. The cranial shunt may also comprise a pressure sensor configured to provide intracranial pressure (ICP) of the patient to the microcontroller, and a tilt sensor configured to provide an angle of orientation relative to gravity of a cranium of the patient to the microcontroller, where the valve assembly passes or blocks the CSF flow to the second catheter based on instructions from the microcontroller.

An anatomical manipulation device having a plurality of actuators configured around an anatomical interface. The device includes a controller, an interactive communication interface and at least one feedback sensor to measure physiological responses. The interactive communication interface receives input from the user. The controller coordinates the operation of the actuators based on the measurements received from the feedback sensor and input from the interactive communication interface. Each actuator includes one or more of: a high-intensity focused ultrasound (HIFU) probe, an electrical muscle stimulator, a low-frequency pulse generator, a sound wave generator and a micro-vibrator.

Embodiments of a system for improved interrogation of shunt functionality are disclosed. The system includes a fluid flow detector having a microfluidic chamber configured for receiving the passage of bodily fluid flow. The fluid flow detector generates measurements and other data and provides wireless access to the same.

The invention relates to an in-utero ventriculoamniotic shunting device that includes a composite shunt tube composed of polymer material, e.g., silicone-based material, and metallic wire, having a bend or curve formed in the length of the shunt tube, with one or more anchors composed of super-elastic wire or mesh, e.g., shape memory alloy wire or mesh structures, attached to the shunt tube, and a one-way passive valve composed of a thin polymer membrane. The anchors are effective to prevent migration and dislodgement of the shunting device following its deployment, and the valve is effective to prevent the backflow of amniotic fluid.

An externally programmable shunt valve assembly that includes a motor having a rotor that is operable in response to an externally applied magnetic field and configured to increase or decrease the working pressure of the shunt valve assembly. The motor may further include a position sensing mechanism that allows a position of the rotor, and associated pressure setting of the valve, to be determined using an external magnetic sensor. In certain examples the motor further includes a mechanical brake that is magnetically operable between a locked position and an unlocked position and which, in the locked position, prevents rotation of the rotor.

Methods, devices, systems, and/or kits that encompass various components for accessing cerebrospinal fluid (CSF) in a CSF containing space of a subject to drain the CSF into a dural venous sinus (DVS) of the subject via a single cranial hole are disclosed herein. The described methods, devices, systems and/or kits drain the CSF into the DVS to treat hydrocephalus in a manner that does not require penetration into the gray matter of the subject's brain.